Carla Prado, PhD, RD

Professor, Faculty of Agricultural, Life and Environmental Sci - Ag, Food & Nutri Sci Dept


Professor, Faculty of Agricultural, Life and Environmental Sci - Ag, Food & Nutri Sci Dept
(780) 492-7934
2-021E Li Ka Shing Centre For Research
11203 - 87 Ave NW
Edmonton AB
T6G 2H5



Education, Training and Employment History

Assistant Professor – Department of Nutrition, Food and Exercise Sciences, Florida State University, USA.

Visiting Scholar - Institute for Ageing and Health, Newcastle University, UK.

Postdoctoral Fellowship - NIDDK, National Institutes of Health, USA.

Postdoctoral Fellowship - Department of Oncology/Cross Cancer Institute, University of Alberta, CA.

PhD - Nutrition & Metabolism, Department of Agricultural, Food and Nutritional Sciences, University of Alberta, CA.

Postgraduate Degree (Specialist) - Academic Teaching, FacLions, BR.

Undergraduate - Nutrition/Internship, UFG, BR.

Research Area

Nutritional Assessment / Clinical Nutrition


Dr. Carla Prado, PhD, RD is a Professor at the University of Alberta, a Campus Alberta Innovates (CAIP) Chair in Nutrition, Food and Health, and a Canadian Institutes of Health Research (CIHR) New Investigator. She is the Director of the Human Nutrition Research Unit, a state-of-the-art research and training facility. Her laboratory is dedicated to the study of nutrient intake, energy metabolism and skeletal muscle and adipose tissue dynamics and its effect on health. Dr. Prado was recognized as one of the most influential young Canadian leaders, receiving Canada’s Top 40 Under 40 Award. 

Dr. Prado is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism; she has published over 160 peer-reviewed publications on the topic (h-index=46; i10-index=97). Her research has shown for the first time the prevalence and clinical implications of sarcopenic obesity (concurrent appearance of low muscle and high fat) in cancer, and has provided evidence of the independent effect of body composition on cancer recurrence, treatment and survival. Her expertise also includes the assessment of whole-body macronutrient metabolism and the regulation of body weight and composition. The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of abnormal body composition in patients with diverse chronic conditions. She is currently the Principal Investigator of three randomized controlled trials investigating the impact of nutrition intervention on body composition and health.

Dr. Prado received her Ph.D. from the University of Alberta, Canada, and has completed further training at the Cross Cancer Institute (Canada), the National Institutes of Health (USA) and Newcastle University (UK). She is an Associate Editor of Clinical Nutrition and the Journal of Cachexia, Sarcopenia and Muscle. She serves as a member of the Body Composition Clinical Guidelines group for the American Society for Parenteral and Enteral Nutrition. In addition to receiving Canada's Top 40 Under 40 Award in 2019, Dr. Prado has also received Avenue Edmonton's Top 40 Under 40, an award that celebrates Alberta’s most exceptional young community and corporate leaders (2017). 


NUTR 482 - Introduction to Dietetic Practice (Winter 2018).

NUTR 440 - Current Topics in Nutritional Science (Winter 2016, 2017).


Global News featured one of our studies. Watch it here:

Ms Scientist Documentary. Watch it here (Canada):

Outside of Canada (


AFNS 603 - Graduate Research Project

Directed laboratory study under supervision of a Faculty member. Note: May be taken more than once if the topic is different. Prerequisite: consent of Department.

Browse more courses taught by Carla Prado


The association between body composition and toxicities from the combination of Doxil and trabectedin inpatients with advanced relapsed ovarian cancer

Author(s): Prado CM, Baracos VE, Xiao J, Birdsell L, Stuyckens K, Park YC, Parekh T, Sawyer MB
Publication Date: 2014
Publication: Applied Physiology, Nutrition, and Metabolism.
Volume: 39
Issue: 6
Page Numbers: 693-698

Body composition in chemotherapy: the promising role of CT scans

Author(s): Prado CM
Publication Date: 2013
Publication: Current Opinion in Clinical Nutrition and Metabolic Care
Volume: 16
Issue: 5
Page Numbers: 525-533

Sarcopenia and Physical Function in Overweight Patients with Advanced Cancer

Author(s): Prado CM, Lieffers JR, Bowthorpe L, Baracos VE, Mourtzakis M, McCargar LJ
Publication Date: 2013
Publication: Canadian Journal of Dietetic Practice and Research
Volume: 74
Issue: 2
Page Numbers: 69-74

The central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?

Author(s): Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, Antoun S, Baracos V
Publication Date: 2013
Publication: American Journal of Clinical Nutrition.
Volume: 98
Issue: 4
Page Numbers: 1012-1019

Dietary patterns of patients with advanced lung or colorectal cancer.

Author(s): Prado CM, Lieffers JR, Bergsten G, Mourtzakis M, Baracos V, McCargar LJ
Publication Date: 2012
Publication: Canadian Journal of Dietetic Practice and Research
Volume: 73
Issue: 4
Page Numbers: e298-303

Effects of intentional weight loss on physical and cognitive function in middle-aged and older obese subjects: a pilot study

Author(s): Siervo M, Nasti G, Stephan BCM, Papa A, Muscariello E, Wells JCK, Prado CM, Colantuoni A
Publication Date: 2012
Publication: Journal of The American College of Nutrition
Volume: 31
Issue: 2
Page Numbers: 79-86

Sarcopenic Obesity: A Critical Appraisal of the Current Evidence

Author(s): Prado CM, Wells JCK, Smith S, Stephan BCM, Siervo M
Publication Date: 2012
Publication: Clinical Nutrition.
Volume: 31
Issue: 5
Page Numbers: 583-601

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

Author(s): Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB
Publication Date: 2009
Publication: Clinical Cancer Research
Volume: 15
Issue: 8
Page Numbers: 2920-2926

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

Author(s): Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, and Baracos VE
Publication Date: 2008
Publication: Lancet Oncology
Volume: 9
Issue: 7
Page Numbers: 629-635

A population-based approach to define body-composition phenotypes

Author(s): Prado CM, Siervo M, Mire E, Heymsfield SB, Stephan BC, Broyles S, Smith SR, Wells JC, Katzmarzyk PT
Publication: The American Journal of Clinical Nutrition

Assessment of nutritional status in cancer – the relationship between body composition and pharmacokinetics

Author(s): Prado CM, Maia YLM, Ormsbee M, Sawyer M. Baracos VE
Publication: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13
Issue: 8
Page Numbers: 1197-1203

Association of the body adiposity index (BAI) with metabolic risk factors in young and older overweight and obese women

Author(s): Siervo M, Prado CM, Stephan BC, Lara J, Muscariello E, Nasti G, Colantuoni A
Publication: Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity

Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma

Author(s): Meza-Junco, Montano-Loza AJ,Baracos VE, Prado CM, Bain VG, Beaumont, C, Esfandiari N, Lieffers JR, Sawyer MB
Publication: Journal of Clinical Gastroenterology.
Volume: 47
Issue: 10
Page Numbers: 861-870